Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Sussman, G. L.
space
  arrow  Beezhold, D. H.
space
 arrow  PubMed                        
space

REPLY

Safe Use of Latex Rubber

right arrow Gordon L. Sussman and Donald H. Beezhold

1 August 1995 | Volume 123 Issue 3 | Pages 234-235


IN RESPONSE:

Latex allergy is a significant occupational hazard affecting 5% to 10% of health care workers. Latex-related illness causes severe morbidity and potentially life-threatening anaphylactic shock [1]. A clear hospital policy is necessary to deal with this increasingly important problem.

Nonallergenic natural rubber latex is not currently available. Because latex-allergic patients have reported severe clinical allergy to low-protein latex gloves, we cannot recommend their use in persons with a positive history, skin test result, or radioallergosorbent test result. Patients with clear histories of latex-induced contact urticaria, rhinitis, conjunctivitis, asthma, and anaphylaxis can safely use most nonlatex alternatives to prevent allergic consequences.

However, several issues are important in choosing an alternative. Studies have reported increased viral leakage through vinyl substitutes [2]. We do not believe that vinyl be considered as an adequate alternative to latex in high-risk situations. Other nonlatex substitutes are available and should be used by patients allergic to latex.

The use of powder-free latex will not prevent clinical allergy in sensitized persons but will decrease airborne latex and allow allergic patients to continue to work [3]. Powder-free gloves would significantly decrease but not completely eliminate inhalation of latex, one very important route of sensitization. Powder-free gloves would also reduce other complications in surgery [4].

The cost of powder-free latex gloves is competitive with that of powdered examination and surgical gloves, but there may be limited availability. We recommend that low-allergen, powder-free latex gloves be used by all health care workers except patients with known latex allergies.

Government agencies must recognize latex allergy as a real and significant health hazard. The government must also regulate the safe use of latex. This includes adequate labeling of products so that the material of manufacture is clearly identified. The term hypoallergenic should be removed and replaced by meaningful values for latex protein, chemical additives, and glove powder. Manufacturers must voluntarily lower the allergenic content of their latex gloves to prevent sensitization and latex allergic illness.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Emory Clinic; Atlanta, GA 30322
The New York Hospital-Cornell Medical Center; New York, NY 10021
Guthrie Foundation for Medical Research; Sayre, PA 18840.


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Ownby DR, Tonlanovich M, Sammons N, McCullough J. Anaphylaxis associated with latex allergy during barium enema examinations. AJR Am J Roentgenol. 1991; 156:903-8.

2. Korniewicz DM, Laughton BE, Cyr WH, et al. Leakage of virus through used vinyl and latex examination gloves. J Clin Microbiol. 1990; 28:787-8.

3. Tarlo SM, Sussman GL, Contala A, Swanson MC. Control of airborne latex by use of powder-free latex gloves. J Allerg Clin Immunol. 1994; 93:985-9.

4. Beck WC, Beezhold DH. Starch powder should follow talc into limbo (Editorial). J Am Coll Surg. 1994; 178:185-6.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Sussman, G. L.
space
  arrow  Beezhold, D. H.
space
 arrow  PubMed                        
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online